Bio-Thera Reports Positive Bevacizumab Results

Avastin Rival Is Firm’s Second Biosimilar With Positive Phase III Outcome

 
• By David Wallace
  
Clinical_Trial_Tablet
Bio-Thera Reports Positive Results For Its Bevacizumab Candidate • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products